1. Home
2. ICD-10 Codes
3. Chapter - G00-G99
4. Section - G10-G14
5. Category - G13
6. G13.2

G13.2 - Systemic atrophy primarily affecting the central nervous system in myxedema

• Applicable to Systemic atrophy primarily affecting the central nervous system in myxedema
• The 2025 edition of ICD10-CM G13.2 became effective on October 1, 2024.
• This is the American ICD10-CM version of G13.2 - other international versions of ICD10 G13.2 may differ.
• G13.2 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

codefirst

• underlying disease, such as:
• hypothyroidism (E03.-)
• myxedematous congenital iodine deficiency (E00.1)

The following codes above G13.2 contain annotation back-references that may be applicable to G13.2:

• Chapter: G00-G99 - Diseases of the nervous system
• Section: G10-G14 - Systemic atrophies primarily affecting the central nervous system
• Category: G13 - Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

Browse other similar CM codes:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.